Pharmaceutical

Santa Ana Bio secures $168m for inflammatory disease treatments

Precision immunology company Santa Ana Bio has announced a substantial funding injection of $168m through Series A and B financing rounds.

Jun 16, 2024 - 04:00
Santa Ana Bio secures $168m for inflammatory disease treatments
Precision immunology company Santa Ana Bio has announced a substantial funding injection of $168m through Series A and B financing rounds.
Read the original article

Tags:

Previous Article

Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research

Next Article

Suven Pharmaceuticals to gain controlling stake in Sapala Organics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs

Seaport raises $225m to advance portfolio of neuropsych...

Oct 22, 2024

‘Patients are not hot potatoes’: How the fight over dialysis coverage is putting kidney failure patients at risk

‘Patients are not hot potatoes’: How the fight over dia...

May 5, 2023

Zealand raises DKr1.45bn to advance obesity pipeline

Zealand raises DKr1.45bn to advance obesity pipeline

Jan 9, 2024